rs10941112

This is a variant in the AMACR gene that changes a glycine to an aspartate.

GWAS Catalog Trait Associations (1)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

ClinVar annotation

Benign★★★
9 submitters2 publications

Alpha-methylacyl-CoA racemase deficiency (AMACRD); Congenital bile acid synthesis defect 4 (CBAS4); not specified

View on ClinVar →

Research that mentions this SNP (3)

Exome sequences of multiplex, multigenerational families reveal schizophrenia risk loci with potential implications for neurocognitive performance
AssociationN=136Mark Z. Kos et al.(2017)· American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

Exome sequencing of 136 individuals from 8 multiplex families identified two protein-altering variants associated with schizophrenia: rs10941112 (G175D, P=2.1×10⁻⁵) in AMACR (fatty acid metabolism gene) and rs10378 (L187F, P=2.8×10⁻⁵) in TMEM176A. rs10941112 showed significant cis effects on AMACR expression (P=5.5×10⁻⁴) in both study samples and GTEx brain tissues. Pathway analyses implicated genes involved in synaptic plasticity and NCAM-mediated neurite outgrowth.

Traits studied:Neurocognitive performance (PCET efficiency)Schizoaffective disorderSchizophrenia
AMACR polymorphisms, dietary intake of red meat and dairy and prostate cancer risk
AssociationN=2,576Jonathan L. Wright et al.(2011)· The Prostate

Population-based case-control study of 1,309 prostate cancer cases and 1,267 controls examined AMACR polymorphisms and their relationship with prostate cancer risk and dietary red meat/dairy intake. Carriers of the rs2287939 T allele showed a 19% reduction in risk for less aggressive prostate cancer (OR=0.81, 95% CI 0.68-0.97) but no alteration in risk for more aggressive disease. Red meat consumption was associated with increased prostate cancer risk, particularly for aggressive disease, but no gene-environment interaction was observed.

Traits studied:Prostate cancerProstate cancer aggressiveness
Bladder cancer SNP panel predicts susceptibility and survival
AssociationN=2,023Angeline S. Andrew et al.(2009)· Human Genetics

A population-based case-control study of 832 bladder cancer cases and 1,191 controls examining SNPs in cancer-regulatory pathways identified increased risk associated with MTHFD2 (OR 1.7, 95% CI 1.3-2.3), TEP1 (OR 1.8, 95% CI 1.2-2.6), and decreased risk with IL8RB (OR 0.6, 95% CI 0.5-0.9). Survival analysis found shorter survival with CASP9 variants (HR 1.8, 95% CI 1.1-3.0) and longer survival with EPHX1 variants (HR 0.4, 95% CI 0.2-0.8). Multi-SNP combinations in metabolism, DNA repair, telomerase, and apoptosis pathways were also predictive of bladder cancer risk and prognosis.

Traits studied:Bladder cancer survivalBladder cancer susceptibility

About AMACR

This gene encodes a racemase. The encoded enzyme interconverts pristanoyl-CoA and C27-bile acylCoAs between their (R)- and (S)-stereoisomers. The conversion to the (S)-stereoisomers is necessary for degradation of these substrates by peroxisomal beta-oxidation. Encoded proteins from this locus localize to both mitochondria and peroxisomes. Mutations in this gene may be associated with adult-onset sensorimotor neuropathy, pigmentary retinopathy, and adrenomyeloneuropathy due to defects in bile acid synthesis. Alternatively spliced transcript variants have been described. Read-through transcription also exists between this gene and the upstream neighboring C1QTNF3 (C1q and tumor necrosis factor related protein 3) gene. [provided by RefSeq, Mar 2011]

View all AMACR variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…